Axcelis Tech Ord Stock Price, News & Analysis

Axcelis Technologies (NASDAQ: ACLS) will participate in the virtual D.A. Davidson Semicap, Laser and Optical Conference on December 15, 2020. The management team will hold one-on-one meetings throughout the event. With over 40 years of experience, Axcelis supplies innovative ion implantation solutions critical to the semiconductor industry's manufacturing process.

Axcelis Technologies (ACLS) reported third-quarter 2020 revenue of $110.4 million, down from $123 million in Q2 2020. Operating profit decreased to $13.9 million, while net income was $10.8 million or $0.32 per diluted share, compared to $13.3 million or $0.39 per diluted share in the previous quarter. Gross margin improved to 43.6%. Cash and equivalents rose to $212.7 million. For Q4, revenue is projected to be around $110 million with a 41% gross margin and earnings per share of $0.21.

Axcelis Technologies (Nasdaq: ACLS), based in Beverly, Mass., is set to participate in the Benchmark Technology Conference on November 12th, 2020. The conference will be conducted virtually, featuring one-on-one meetings hosted by Doug Lawson, the executive vice president of corporate marketing and strategy. Investors interested in attending can get more details and schedule meetings through the Benchmark website.

With over 40 years in the industry, Axcelis specializes in ion implantation solutions crucial for semiconductor manufacturing.

Axcelis Technologies announced the shipment of multiple Purion VXE and Purion EXE high energy systems to major CMOS image sensor manufacturers. These systems, part of the Purion high energy implanter series, support advanced applications in the growing IoT and mobile markets. Bill Bintz, Executive Vice President, emphasized the demand for these high energy implants, which offer precise doping profiles. This development further strengthens Axcelis' leadership position in the semiconductor industry, showcasing a robust product portfolio designed to meet customer needs.

Axcelis Technologies (ACLS) will announce its third quarter 2020 financial results on November 5, 2020, at 4:00 p.m. ET. Following the release, a conference call will be held on November 6, 2020, at 8:30 a.m. ET, accessible via audio webcast on Axcelis' investor page. Participants can ask questions by dialing 866.588.8911 (or 707.294.1561 internationally) with Conference ID: 1999553. Axcelis has been innovating in the semiconductor industry for over 40 years, focusing on ion implantation systems.

Axcelis Technologies (Nasdaq: ACLS) announced the shipment of its first Purion H200 high current implanter evaluation system and a follow-on order for the Purion M SiC medium current implanter to leading power device manufacturers. The Purion H200 is designed for Si power device production, while the Purion M SiC system supports fab capacity expansion. Both systems were shipped in Q3 2020. CEO Mary Puma emphasized the importance of expanding their customer footprint in the power device market to achieve the company's long-term $650M business model.

On September 16, 2020, Axcelis Technologies (Nasdaq: ACLS) announced the shipment of multiple evaluation systems for its next-generation Purion H to customers in the Asia Pacific region. This shipment, part of their third-quarter activities, is aimed at advanced logic and 3D NAND memory device manufacturers. CEO Mary Puma highlighted the significance of these shipments for growth in the high current ion implant market, projecting a long-term business model worth $650M. The Purion H platform features advanced technology designed to meet critical manufacturing challenges.

Axcelis Technologies (Nasdaq: ACLS), a key supplier in the semiconductor industry, will participate in the Needham Virtual SemiCap and EDA Investor Conference on August 13. Executives Mary Puma, Kevin Brewer, and Doug Lawson will lead a fireside chat at 2:15 p.m. EST, with one-on-one meetings available. A live webcast can be accessed via the company's website, and a replay will be available for 30 days post-event. Axcelis has over 40 years of experience in ion implantation systems for IC manufacturing.

Axcelis Technologies reported a strong second quarter for 2020, with revenue increasing to $123 million, up from $119 million in Q1. Operating profit rose to $16.4 million, and net income reached $13.3 million, or $0.39 per diluted share. The gross margin improved to 42.2%, compared to 38.3% in the previous quarter. Cash reserves increased to $197 million. For Q3 2020, Axcelis anticipates revenues around $110 million and earnings per share of approximately $0.24.